TransMedics to Present at the Cowen 42nd Annual Healthcare Conference

TransMedics Group (Nasdaq: TMDX) will present at the Cowen 42nd Annual Healthcare Conference on March 9, 2022, at 9:50 a.m. EST.

Rhea-AI Summary

TransMedics Group (Nasdaq: TMDX) will present at the Cowen 42nd Annual Healthcare Conference on March 9, 2022, at 9:50 a.m. EST. The executive team's presentation aims to highlight advancements in organ transplant therapy, particularly for patients experiencing end-stage lung, heart, and liver failure. TransMedics is a leader in portable warm perfusion technology, focusing on improving organ quality and viability assessment prior to transplantation.

Investors can access a live and archived webcast of the presentation on the TransMedics website.

Argus Session date unavailable

-5.27% session move Open Argus

Details

News Market Reaction – TMDX

The recorded move for TMDX in the trading session of this news was -5.27%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., Feb. 22, 2022 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that members of the management team will present virtually at the upcoming Cowen 42^nd Annual Healthcare Conference. Management is scheduled to present on Wednesday, March 9, 2022, at 9:50 a.m. Eastern Standard Time.

Event: Cowen 42^nd Annual Healthcare Conference
Date: Wednesday, March 9, 2022
Time: 9:50 a.m. EST

A live and archived webcast of the presentation will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-present-at-the-cowen-42nd-annual-healthcare-conference-301486137.html

SOURCE TransMedics Group, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is TransMedics presenting at the Cowen 42nd Annual Healthcare Conference?

TransMedics will present on advancements in organ transplant therapy for patients with end-stage lung, heart, and liver failure on March 9, 2022.

When is the Cowen 42nd Annual Healthcare Conference presentation scheduled?

The presentation is scheduled for March 9, 2022, at 9:50 a.m. Eastern Standard Time.

Where can I watch the TransMedics presentation?

You can watch the live and archived webcast of the presentation on the TransMedics 'Investors' section of their website.

What is TransMedics known for?

TransMedics is known for its portable extracorporeal warm perfusion technology, which enhances organ quality and viability assessments for transplantation.